160 related articles for article (PubMed ID: 17316287)
1. The CARI guidelines. Choice of calcineurin inhibitors in adult renal transplantation: effects on transplant outcomes.
Pilmore H;
Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S88-97. PubMed ID: 17316287
[No Abstract] [Full Text] [Related]
2. The CARI guidelines. Calcineurin inhibitors in paediatric renal transplantation.
McTaggart S;
Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S106-10. PubMed ID: 17316270
[No Abstract] [Full Text] [Related]
3. The CARI guidelines. Calcineurin inhibitors in renal transplantation: therapeutic drug monitoring.
Trevillian P;
Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S57-65. PubMed ID: 17316283
[No Abstract] [Full Text] [Related]
4. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
Nashan B
Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
[TBL] [Abstract][Full Text] [Related]
5. The CARI guidelines. Calcineurin inhibitors in renal transplantation: nephrotoxicity and calcineurin inhibitors.
Coates PT;
Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S85-7. PubMed ID: 17316286
[No Abstract] [Full Text] [Related]
6. The CARI guidelines. Calcineurin inhibitors in renal transplantation: adverse effects.
Jose M;
Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S66-74. PubMed ID: 17316284
[No Abstract] [Full Text] [Related]
7. Calcineurin inhibitors in heart transplantation.
Crespo-Leiro MG
Transplant Proc; 2005 Nov; 37(9):4018-20. PubMed ID: 16386614
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic monitoring of calcineurin inhibitors for the nephrologist.
Schiff J; Cole E; Cantarovich M
Clin J Am Soc Nephrol; 2007 Mar; 2(2):374-84. PubMed ID: 17699437
[TBL] [Abstract][Full Text] [Related]
9. The CARI guidelines. Calcineurin inhibitors in renal transplantation: pregnancy, lactation and calcineurin inhibitors.
Grimer M;
Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S98-S105. PubMed ID: 17316288
[No Abstract] [Full Text] [Related]
10. [Controversies about the use of calcineurin inhibitors in pediatric patients].
Dello Strologo L
G Ital Nefrol; 2008; 25(3):317-24. PubMed ID: 18473303
[TBL] [Abstract][Full Text] [Related]
11. [Immunosuppressive therapy without calcineurin inhibitors for renal transplants? Perhaps we should be cautions...].
Fasoli G
G Ital Nefrol; 2007; 24(2):110. PubMed ID: 17458825
[No Abstract] [Full Text] [Related]
12. Calcineurin inhibitor toxicity in renal allografts: morphologic clues from protocol biopsies.
Sharma A; Jain S; Gupta R; Guleria S; Agarwal S; Dinda A
Indian J Pathol Microbiol; 2010; 53(4):651-7. PubMed ID: 21045386
[TBL] [Abstract][Full Text] [Related]
13. Impaired erythropoietin production in liver transplant recipients: the role of calcineurin inhibitors.
Bardet V; Junior AP; Coste J; Lecoq-Lafon C; Chouzenoux S; Bernard D; Soubrane O; Lacombe C; Calmus Y; Conti F
Liver Transpl; 2006 Nov; 12(11):1649-54. PubMed ID: 17058250
[TBL] [Abstract][Full Text] [Related]
14. Future of the pharmacogenomics of calcineurin inhibitors in renal transplant patients.
Zhu H; Ge W
Pharmacogenomics; 2011 Nov; 12(11):1505-8. PubMed ID: 22044409
[No Abstract] [Full Text] [Related]
15. Induction of the unfolded protein response by calcineurin inhibitors: a double-edged sword in renal transplantation.
Kitamura M
Nephrol Dial Transplant; 2010 Jan; 25(1):6-9. PubMed ID: 19797334
[No Abstract] [Full Text] [Related]
16. Increase in renal vascular resistance after intake of cyclosporin A and tacrolimus and reversal by nitroglycerin spray: a study in patients with stable renal allograft function.
Weingart C; Leingärtner T; Bergler T; Krüger B; Böger C; Mack M; Banas B; Krämer BK
Int J Clin Pharmacol Ther; 2006 Sep; 44(9):422-7. PubMed ID: 16995330
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
Calvo-Turrubiartes M; Romano-Moreno S; García-Hernández M; Chevaile-Ramos JA; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271
[TBL] [Abstract][Full Text] [Related]
18. Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine.
Jardine AG
Transpl Int; 2005 Apr; 18(4):379-84. PubMed ID: 15773954
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of calcineurin antagonists.
Kapturczak MH; Meier-Kriesche HU; Kaplan B
Transplant Proc; 2004 Mar; 36(2 Suppl):25S-32S. PubMed ID: 15041303
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive strategies in renal transplantation at the beginning of the third millennium.
Abramowicz D; Wissing KM; Broeders N
Adv Nephrol Necker Hosp; 2000; 30():9-28. PubMed ID: 11068631
[No Abstract] [Full Text] [Related]
[Next] [New Search]
